All In Biotech

Drug Trial Radar · NCT00712140

Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer

Persephone: Duration of Trastuzumab With Chemotherapy in Women With Early Stage Breast Cancer: Six Months Versus Twelve

Last checked: Nov 20, 2026Latest source record: Sep 2, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 4,000 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

4,000

Planned (sponsor's estimate)

Start

Oct 2007

Primary completion

Oct 2011

Sponsor

Lead sponsor
Warwick Medical SchoolAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 9, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. It is not yet known which regimen of trastuzumab is more effective in treating early breast cancer. PURPOSE: This randomized phase III trial is comparing two trastuzumab regimens to see how well they work in treating women with HER2-positive early breast cancer.

Conditions

  • Breast Cancer

Interventions

  • trastuzumabBiological

    Given IV

  • parenteral chemotherapyDrug

    per the local institutional protocols either concurrently with or sequentially to trastuzumab

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Disease-free survival

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Addenbrooke's Hospital

    Cambridge, England, United Kingdom · Recruiting

  • Cumberland Infirmary

    Carlisle, England, United Kingdom · Recruiting

  • Derbyshire Royal Infirmary

    Derby, England, United Kingdom · Recruiting

  • Eastbourne District General Hospital

    Eastbourne, England, United Kingdom · Recruiting

  • Luton and Dunstable Hospital

    Luton, England, United Kingdom · Recruiting

  • Clatterbridge Centre for Oncology

    Merseyside, England, United Kingdom · Recruiting

  • James Cook University Hospital

    Middlesbrough, England, United Kingdom · Recruiting

  • Mount Vernon Cancer Centre at Mount Vernon Hospital

    Northwood, England, United Kingdom · Recruiting

  • Peterborough Hospitals Trust

    Peterborough, England, United Kingdom · Recruiting

  • New Cross Hospital

    Wolverhampton, England, United Kingdom · Recruiting

  • Aberdeen Royal Infirmary

    Aberdeen, Scotland, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.